Breo Ellipta basics Breo Ellipta is used to prevent symptoms of chronic obstructive pulmonary disorder (COPD) or asthma. It’s not meant to be used as a rescue inhaler for sudden breathing problems.

Breo Ellipta comes as a gray and light blue plastic inhaler. The inhaler contains two foil strips with 30 blisters each. A blister is a compartment that contains a specific amount of the drug.

The average age was 53 years old. This study compared Trelegy to another inhaler (Breo Ellipta) that contained two long-acting medicines, fluticasone furoate and vilanterol.

In patients 5 to 11 years of age, the difference in LS mean change in FEV 1 (0 to 4 hours) for Breo Ellipta 50/25mcg compared with fluticasone furoate 50mcg was 73mL (95% CI, 28-118).

Breo is a fixed-dose combination of the inhaled corticosteroid (ICS) fluticasone furoate (FF) and the long-acting beta2-agonist (LABA) vilanterol. Two strengths, 100/25mcg and 200/25mcg, have been ...

GSK caps asthma and COPD medicine costs at $35/month, effective Jan 1, 2025. Includes Advair, Breo, Ventolin. Follows AstraZeneca's suit for their respiratory medicines. Sanders applauds move amid ...

The agency cleared the Breo Ellipta inhaler for long-term use and to control flare-ups in patients with chronic obstructive pulmonary disorder, often called smoker’s cough. The lung ailment can ...

Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) is designed to reduce lung inflammation and to relax muscles that impact the lung airways, the FDA said Friday in a news release.

Trelegy Ellipta contains three long-acting medicines and should only be used once each day. For some people with COPD, this will be the only inhaler they need to use every day to control symptoms.